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Abstract
The Rosetta de novo enzyme design protocol has been used to design enzyme catalysts for a variety of chemical reactions,
and in principle can be applied to any arbitrary chemical reaction of interest, The process has four stages: 1) choice of a
catalytic mechanism and corresponding minimal model active site, 2) identification of sites in a set of scaffold proteins
where this minimal active site can be realized, 3) optimization of the identities of the surrounding residues for stabilizing
interactions with the transition state and primary catalytic residues, and 4) evaluation and ranking the resulting designed
sequences. Stages two through four of this process can be carried out with the Rosetta package, while stage one needs to
be done externally. Here, we demonstrate how to carry out the Rosetta enzyme design protocol from start to end in detail
using for illustration the triosephosphate isomerase reaction.
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Introduction
There has been exciting recent progress in computational
enzyme design. Active enzymes have been designed for a variety of
reactions including the Diels-Alder reaction [1], the Kemp
elimination [2], and the retro-aldol reaction [3]. This paper
describes in detail the protocol used to design these catalysts to
help researchers apply the method to new reactions, and discusses
routes for further improvement of the methods.
Enzymesacceleratereactionsthroughinteractionsthatstabilizethe
transition state [4]. The Rosetta enzyme design protocol starts with
minimalist active site descriptions consisting of transition state models
surrounded by disembodied side chain and backbone functional
groupspositioned optimallyfor catalysis, socalled theozymes[5]. The
Rosetta ‘‘matching’’ algorithm [6] is then used to identify
constellations of backbone positions in a set of scaffold proteins
where the minimalist active sites can be realized. For each such
recapitulation of the minimalist active site in a protein scaffold, the
Rosetta design methodology is used to optimize the surrounding
residues for transition state binding affinity and catalysis. Here, the
Rosetta enzyme design protocol, which has been recently re-
implemented as part of the re-architechturing of the Rosetta
molecular modeling program [7], is described in detail using as an
example the isomerization of Dihydroxy-acetone-phosphate (DHAP)
to Glyceraldehyde-3-phosphate (GAP) [8](Figure 1). Figure 2 shows
an overview over the different stages of the design process.
Methods
1) Choice of catalytic mechanism and corresponding
theozyme
The first step in the enzyme design process is to model the
reaction transition state(s) and decide on a set of idealized active site
descriptions consisting of disembodied side chain and backbone
functional groups surrounding the transition state in positions
optimal for catalysts. The latter include for example hydrogen bond
acceptors and donors for proton abstraction and proton donation,
positive charges to stabilize developing negative charge in the
transition state, etc. These active site descriptions and geometries
can be obtained from quantum chemistry saddle point calculations,
as in the case of the theozymes pioneered by Ken Houk’s group [9],
from analogy to active sites of known enzymes, from chemical
intuition, or in practice a combination of the above.
Once a theozyme is defined, it needs to be expressed in terms of
a Rosetta geometric constraint file, a ‘‘cstfile.’’ The information in
this cstfile is used both by the Rosetta matcher to try to graft the
desired theozyme onto a scaffold structure, and by the enzyme_de-
sign code to restrain the theozyme residues to the desired
theozyme geometry during sequence optimization and gradient-
based minimization.
The cstfile consists of blocks; for each interaction between two
residues, (i.e. for each theozyme interaction), there needs to be one
block. The example below describes the interaction between a Glu
or an Asp and a ligand abbreviated with name 1n1. In this cstfile,
there needs to be a block of the following format for each catalytic
interaction:
CST::BEGIN
TEMPLATE:: ATOM_MAP: 1 atom_name: C1 C2 O2
TEMPLATE:: ATOM_MAP: 1 residue3: 1n1
TEMPLATE:: ATOM_MAP: 2 atom_type: OOC ,
TEMPLATE:: ATOM_MAP: 2 residue1: ED
CONSTRAINT:: distanceAB: 3.06 0.2 100. 0 0
CONSTRAINT:: angle_A: 73.60 10.0 80.0 360. 1
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19230CONSTRAINT:: angle_B: 120.00 15.0 80.0 360. 1
CONSTRAINT:: torsion_A: -101.20 15.0 60.0 360. 1
CONSTRAINT:: torsion_AB: 180.00 90.0 0.00 360. 3
CONSTRAINT:: torsion_B: 180.00 15.0 0.00 360. 1
CST::END
The information in this block defines constraints between three
atoms on residue 1 and three atoms on residue 2. Up to six
parameters can be specified, representing the ligand’s six rigid-
body degrees of freedom. These parameters are given as one
distance, two angles, and three dihedrals.
The Records indicate the following:
‘CST::BEGIN’ and ‘CST::END’ indicate the beginning and
end of the respective definition block for this catalytic interaction.
The ‘TEMPLATE:: ATOM_MAP:’ records indicate what atoms
are constrained and what type of residue they are in. The number
in column 3 of these records indicates which catalytic residue the
record relates to. It has to be either 1 or 2.
The ‘atom_name’ tag specifies exactly which 3 atoms of the
residue are to be constrained. It has to be followed by the names of
three atoms that are part of the catalytic residue or ligand. In the
above example, for catalytic residue 1, the ligand, atom 1 is C1,
atom 2 is C2, and atom3 is O2. The geometry specified is
visualized in Figure 3, top left panel.
The ‘atom_type’ tag is an alternative to the ‘atom_name’ tag. It
allows more flexible definition of the constrained atoms. It has to
be followed by the Rosetta atom type of the residue’s atom 1. In
case this tag is used, Rosetta will set atom 2 as the` `base atom" (the
parent for an atom in the tree rooted at the backbone growing out
along the side chain) of atom 1, and will set atom 3 as the base
atom for atom 2. There are two advantages to using the
‘atom_type’ tag: first, it allows constraining different residue types
with the same file, e.g. if a catalytic hydrogen bond is required, but
either a SER or THR would do. Second, if a catalytic residue
contains more than one atom of the same type (e.g. atoms OD1
and OD2 of Asp), but it doesn’t matter which of these atoms
mediates the constrained interaction, using this tag will cause
Rosetta to evaluate the constraint for all of these atoms separately
and pick the one with lowest score, i.e. the ambiguity of the
constraint will automatically be resolved.
The ‘residue1’ or ‘residue3’ tag specifies what type of residue is
constrained. ‘residue3’ needs to be followed by the name of the
residue in 3-letter abbreviation. ‘residue1’ needs to be followed by
the name of the residue in 1-letter abbreviation. As a convenience,
if several similar residue types can fulfill the constraint (e.g. either
Asp or Glu), the ‘residue1’ tag can be followed by a string of 1-
letter codes of the allowed residues ( e.g. ‘‘ED’’ for Asp and Glu, or
‘‘ST’’ for Ser and Thr ).
The ‘CONSTRAINT::’ records specify the parameters and the
strengths of the constraint applied between the two residues. Each
of these records is followed by one string and four numbers. The
string can have the following allowed values:
‘distanceAB’ means the distance Res1:Atom1 = Res2:Atom1,
i.e. the distance between atom1 of residue 1 and atom1 of residue
2.
‘angle_A’ is the angle Res1:Atom2 - Res1:Atom1 - Res2:Atom1
‘angle_B’ is the angle Res1:Atom1 - Res2:Atom1 - Res2:Atom2
‘torsion_A’ is the dihedral Res1:Atom3 - Res1:Atom2 -
Res1:Atom1 - Res2:Atom1
‘torsion_AB’ is the dihedral Res1:Atom2 - Res1:Atom1 -
Res2:Atom1 - Res2:Atom2
‘torsion_B’ is the dihedral Res1:Atom1 - Res2:Atom1 -
Res2:Atom2 - Res2:Atom3
Each of these strings is followed by 4 (optionally 5 ) columns of
numbers: x0, xtol, k, covalent/periodicity, and number of samples.
The 1st column, x0, specifies the optimum distance x0 for the
respective value. The 2nd, xtol, column specifies the allowed
tolerance xtol of the value. The 3rd column specifies the force
constant k, or the strength of this particular parameter. If x is the
value of the constrained parameter, the score penalty p(x) applied
will be:
p(x)~
0 if Dx{x0D vxtol
k  (DD x{x0D{xtolD ) otherwise
()
The 4th column has a special meaning in case of the distanceAB
parameter. It specifies whether the constrained interaction is
covalent or not. 1 means covalent, 0 means non-covalent. If the
constraint is specified as covalent, Rosetta will not evaluate the
vdW term between Res1:Atom1 and Res2:Atom1 and their [1,3]
neighbors.
For the other 5 parameters, the 4th column specifies the
periodicity per of the constraint. For example, if x0 is 120 and per
is 360, the constraint function will have a its minimum at 120
degrees. If x0 is 120 and per is 180, the constraint function will
have two minima, one at 120 degrees and one at 300 degrees. If x0
is 120 and per is 120, the constraint function will have 3 minima,
at 120, 240, and 360 degrees.
The 5th column is optional and specifies how many samples the
matcher, if using the classic matching algorithm, will place
between the x0 and x0+- tol value. The matcher interprets the
value in this column as the number of sampling points between
x0+ xtol and x0– xtol, i.e. in the above example, for angle_A, the
matcher will sample values 63.6, 73.6, and 83.6 degrees.
Generally, if the value in this column is n, the matcher will
sample 2n+1 points for the respective parameter. Note that the
number of samples is also influenced by the periodicity, since the
matcher will sample around every x0.
Figure 1. Isomerization of DiDihydroxy-acetone-phosphate (DHAP) to Glyceraldehyde-3-phosphate (GAP).
doi:10.1371/journal.pone.0019230.g001
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each parameter, it is important to remember that the number of
different ligand placements attempted for every protein rotamer
built is equal to the product of the samples for each of the 6
parameters. For example, in the above block there is one sample
for distanceAB, 3 samples for angle_A, 3 samples for angle_B, 3
samples for torsion_A, 3 samples for torsion_B, and 7 samples for
torsion_AB, meaning that for every protein rotamer, the matcher
will attempt to place the ligand in a total of 1*3*3*3*3*7 =567
different conformations.
2) Matching: identifying sites in the scaffold library where
the theozyme can be placed
In this stage, the hypothetical theozyme will be placed into an
existing protein structure with the help of the RosettaMatch
module. The inputs for this stage are the theozyme expressed in
the cstfile format as described above, and a list of protein scaffolds.
The RosettaMatch executable will be run once for each scaffold
and, if the theozyme and the respective scaffold are compatible,
will output a number of so-called matches. A match is defined as
the theozyme grafted into a scaffold, i.e. the amino acid side chains
of the theozyme have been placed on the scaffold backbone, the
ligand has been placed into a cavity of the scaffold without
clashing with the protein backbone or the theozyme side chains,
and the geometric relation between the ligand and the theozyme
side chains is as specified in the theozyme.
To run RosettaMatch, the user has to prepare each scaffold and
decide which of two available algorithms to use for each side chain
of the theozyme. Preparing the scaffold consists of deciding which
residues of the scaffold should be considered when trying to place
the theozyme.
Preparing the scaffold for matching. Usually only a subset
of the scaffold residues are considered during the matching
process, for two reasons: first, residues lining a concave pocket or
cleft of the scaffold are more likely to form a binding site than
residues that are buried in the hydrophobic core or residues that
protrude into the solvent. Trying to design a binding site in the
core of the protein is problematic because it will likely have a
negative effect on the stability of the protein, while creating a
binding site on the surface of the protein is difficult because there
are possibly not enough side chains to contact the ligand from
several sides and thus form a binding surface that is
complementary in shape to the ligand. Second, the more
residues that are considered by the matcher, the higher the
computational requirements in terms of runtime and memory
become, and for theozymes with many degrees of freedom the
matching runtime can quickly become the bottleneck of the whole
process.
Therefore, for each scaffold that is considered by the matcher, a
subset of residues most likely to be part of the binding site need to
be selected, such as residues lining a pocket or cleft. In case the
scaffold was crystallized with a natural ligand, one could for
example select all residues that are within a certain distance from
that natural ligand.
Choosing a matching algorithm for each theozyme
interaction. RosettaMatch can place the theozyme side
chains through two algorithms: classic matching as introduced
by Zanghellini et al. [6], and "secondary matching." Both
algorithms can be used in the same matching run.
Classic matching has been described in detail before [6]. Briefly,
for every interaction/side chain of the theozyme, the matcher
builds rotamers at each of the scaffold active-site positions. For
each rotamer built, the ligand is placed according to the geometry
specified in the theozyme/cstfile. To use the classic matching
algorithm, sample values must be given for all 6 parameters
connecting the side chain to the transition state. Note that
depending on the theozyme and the set of sample values specified
in the cstfile, the number of different ligand placements for each
side chain rotamer can grow to be quite large. Each ligand
placement is checked for collisions with the scaffold’s backbone,
and, if there are none, the location and orientation of the ligand in
space is recorded in a 6D coordinate (3 Euclidean coordinates and
Figure 2. Flowchart of the enzyme design protocol, colored
according to the different stages. Stage 1: light green; Stage 2:
green; Stage 3: cyan; Stage 4: blue.
doi:10.1371/journal.pone.0019230.g002
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ligand placement along with the side chain rotamer used to build
this coordinate, is called a "hit."
For a theozyme interaction/side chain to be placed with the
secondary matching algorithm, the matcher proceeds as follows:
First, just like in classic matching, rotamers at all scaffold active-
site positions are built. Then, for each rotamer r, the geometry
between r and each of the previously generated hits is evaluated. If
the geometry of rotamer r and a particular hit h is compatible with
the desired theozyme geometry, the 6D coordinate of the ligand is
copied from h and stored with rotamer r as a new hit for this
theozyme interaction.
Figure 3. Theozyme geometries. Top left: Interaction 1; top right: Interaction 3; bottom: Interaction 2; Color scheme: distanceAB: blue, angle_A:
purple, angle_B: yellow, torsion_A: cyan, torsion_AB: orange, torsion_B: ligt brown.
doi:10.1371/journal.pone.0019230.g003
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of the theozyme, all hits are then binned according to the 6D
coordinate of the ligand and placed into a hash table. Then, the
hash bins are checked for whether they contain at least one hit
from each of the N theozyme side chains. For every bin that does,
the ligand placements stored in it, together with the side chain
rotamers they were built from, are considered a "match", i.e. a
successful graft of the theozyme onto the scaffold.
Classic matching and secondary matching each have their own
advantages and disadvantages. Which algorithm to choose for a
given theozyme interaction depends on several factors.
There are two advantages to the secondary matching algorithm:
first, since the ligand is not built from the side chain rotamer, but
instead taken from a previously generated hit, not all six degrees of
freedom must be specified. For example, if a theozyme interaction
depends only the distance and the two angles, while the three
dihedrals are unimportant, then the secondary matching algo-
rithm can be given ranges for only the important parameters,
while ignoring the unimportant parameters. If such an interaction
were to be described to the classic matching algorithm, the
unimportant dihedral parameters would have to be sampled over
the whole 360 degree range, resulting in long running times.
Sampling these dihedrals coarsely at 10 degree increments still
requires building 36 ˆ3,46 thousand ligand conformations per
assignment to the other 3 parameters per side chain rotamer.
Second, the secondary matching algorithm can also be used to
find theozyme interactions between two side chains. Since both the
ligand placement and the rotamer from which it stems are stored
in a hit, the secondary matching algorithm can equally well
evaluate the geometry between a rotamer built for one theozyme
interaction and a rotamer for a previously generated hit.
The advantage of the classic matching algorithm is that it
performs considerably faster than the secondary match algorithm
in cases where a large number of ligand placements have been
generated for preceding interactions of the theozyme. The speed
of placing one theozyme interaction with the secondary matching
algorithm decreases with an increasing number of previous ligand
placements, since every one of them needs to be examined again.
The classic match algorithm, on the other hand, always generates
the ligand placements from the coordinates of the side chain
rotamer and the information in the geometric constraint file, and is
thus independent of previously generated ligand placements. It
also is less sensitive to the lever-arm effect than secondary
matching; secondary matching may not capture ligand interaction
geometries very accurately forcing the user either to tolerate very
broad ranges of values for a particular interaction or to sample
ligand geometries very densely in other theozyme interactions.
As a rule of thumb, secondary matching should be used for
theozyme interactions where not all six degrees of freedom are
clearly defined and for side chain-side chain theozyme interac-
tions, while classic matching should be used in other cases. Note
that since secondary matching must rely on the hits generated
prior to its execution, classic matching must be used for the first
theozyme interaction.
Command line options affecting this stage:
Matching is carried out by the matchexecutable available in the
Rosetta 3.2 release and is sensitive to the following command line
options:
-extra_res_fa ,filename. path to rosetta param-
eter file of ligand to be matched
-lig_name ,string. name of the ligand to
be matched
-geometric_constraint_file ,filename. path to constraint file /
theozyme
-s ,filename. path to scaffold pdb
-scaffold_active_site_residues ,filename.file containing what
residues of the scaffold to match at
-ex1, -ex2 ,value. optional parameter
governing size of rotamer library
3) Designing the found sites
After matches have been found, optimal residue identities for
other scaffold positions need to be determined to build an active
site that is complimentary in shape to the ligand while also
stabilizing the catalytic side chains in their matched conforma-
tions. The basic Rosetta enzyme design protocol used for this
consists of four steps, and is all carried out by the enzyme_design
executable available in the Rosetta 3.2 package:
A. Determining which residues to design and which to repack
B. Optimizing the catalytic interactions
C. Cycles of sequence design/minimization (with catalytic
constraints if specified)
D. Unrestrained fixed sequence rotamer pack /minimization
Determining which residues to design and which to
repack. There are two ways of doing this: using a standard
Rosetta resfile to exactly specify which residues are allowed at
which position or automatic detection of the design region. In case
there is only a small number of different starting structures, it is
probably better to invest the time and use intuition to decide which
positions in the protein to redesign or repack and which amino
acids to allow.
In case there are a lot of input structures to be designed, it is also
possible to automatically determine which residues to redesign.
Rosetta can divide the protein’s residues into 5 groups of
increasing distance from the ligand:
1) Residues that have their Ca within a distance cut1 A ˚ of any
ligand heavy atom will be set to designable
2) Residues that have their Ca within a distance cut2 of any
ligand heavy atom and the Cb closer to that ligand atom
than the Ca will be set to designable. cut2 has to be larger
than cut1
3) Residues that have their Ca within a certain distance cut3 of
any ligand heavy atom will be set to repackable. cut3 has to
be larger than cut2
4) Residues that have their Ca within a distance cut4 of any
ligand heavy atom and the Cb closer to that ligand atom will
be set to repackable. cut4 has to be larger than cut3
5) All residues not in any of the above 4 groups are kept static.
Residues declared as catalytic in the input pdb will always be
repackable (except if turned off by an option). At residue positions
that are set to designable, every amino acid except cysteine will be
allowed. Values (in A ˚) for the different cuts commonly used are:
6.0 (cut1), 8.0 (cut2), 10.0 (cut3), and 12.0 (cut4).
Command line options affecting this stage:
-resfile \,name of resfile\. specifies the use
of a resfile
-enzdes:detect_design_interface invokes automatic
detection of designable region
-enzdes:cut1 \,value\. valueusedforcut1
(in A ˚)
-enzdes:cut2 \,value\. valueusedforcut2
(in A ˚)
-enzdes:cut3 \,value\. valueusedforcut3
(in A ˚)
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-enzdes:fix_catalytic_aa prevents catalytic resi-
dues from being repacked or minimized
Further, these two ways of declaring the design and repack
regions can be combined, i.e. a resfile and the detect_design_inter-
face mechanism can be used concurrently. If the default behavior
in the resfile is set to ‘AUTO’, the behavior of every residue which
is not specifically declared in the resfile will be determined
according to the -detect_design_interface logic.
Optimizing catalytic interactions. This stage consists of a
gradient-based minimization of the input structure before design.
During this minimization, all active site residues that are not
catalytic (i.e. not part of the theozyme) are mutated to alanine (i.e.
the active site is reduced to substrate and catalytic residues only),
and a reduced energy function that does not contain vdW-
attractive or solvation terms is used for the minimization.
Restraints as specified in the cstfile are placed on the
interactions between catalytic residues and the ligand. The
purpose of this stage is to move the substrate to a position where
the catalytic interactions are as ideal as possible.
Command line options affecting this stage:
-enzdes:cst_opt will invoke this stage
-enzdes:bb_min optional but recommended. Allows
the backbone to be slightly flexible during the minimi-
zation
-enzdes:chi_min optional but recommended. Allows
the dihedrals of the catalytic residues to move during
the minimization
For backbone minimization, only the backbone phi/psi angles
of residues in the designable/repackable region will be allowed to
move. A special fold tree [10] is created to constrain backbone
movement to the designed site, i.e. there will be no conformational
changes in regions that are neither repackable nor designable.
Further, to prevent the backbone of the active site from moving
considerably during the gradient-based minimization, the Ca
atoms are restrained to within 0.5 A ˚ of their original positions.
An alternative to the gradient-based restraint optimization is
running a short docking trajectory of the ligand with Monte Carlo
rigid body sampling. It is invoked by
-enzdes:cst_predock invokes this stage
-enzdes:trans_magnitude largest allowed displace-
ment of the ligand (in A ˚)
-enzdes:rot_magnitude largest allowed rotation
of the ligand (in degrees)
-enzdes:dock_trials number of rigid body moves
attempted
The trans_magnitude and rot_magnitude values are sampled
with a Gaussian distribution of zero mean and one standard
deviation. The rotation and translation center is taken as the
centroid of the set of ligand atoms which have distance restraints to
the protein. This ensures the most efficient sampling of the ligand
with respect to the restraints. As in Bi, all designable residues are
mutated to alanine to allow the ligand to sample the whole active
site region prior to design.
Cycles of sequence design and minimization. This is
where the actual sequence design happens. At the designable
positions, the Rosetta standard Monte Carlo algorithm is
employed to find a new lower energy sequence for the non-
catalytic residues. The catalytic restraints are kept on through the
entirety of this stage. After sequence design, the resulting structure
is minimimized. These two steps are typically iterated upon a small
number of times (2–4).
Command line options affecting this stage:
-enzdes:cst_design will invoke this stage
-enzdes:design_min_cycles how many iterations of
design/minimization will be done
-enzdes:lig_packer_weight determines the relative
importance of protein-substrate interactions vs. pro-
tein-protein interactions in the sequence selection
calculation
-enzdes:cst_min necessary to invoke min-
imization after sequence design
-enzdes:bb_min same as for stage B
-enzdes:chi_min same as for stage B
-packing:ex1 optional but highly rec-
ommended. improved rotamer sampling around the first
dihedral for every amino acid
-packing:ex2 optional but highly rec-
ommended. improved rotamer sampling around the second
dihedral for every amino acid
-packing:use_input_sc optional but highly rec-
ommended. include the input rotamer of every side chain
in the calculation
-packing:soft_rep_design triggers use of the soft-
repulsive force field in design.
-packing:linmem_ig 10 optional but highly rec-
ommended. speeds up the sequence design step while at
the same time reducing memory requirements.
-packing:unboundrot optional. pdb files that
contain additional rotamers to use in rotamer packing
calculations.
Unrestrained fixed-sequence rotamer packing and
minimization. After Rosetta has designed a new sequence, a
final repack/minimization will be done without the catalytic
restraints. This is to check whether the designed sequence actually
holds the catalytic residues in their catalytically active
conformations; in a good design, the catalytic residues should
adapt their theozyme conformations without artificial restraints
enforcing them.
Command line options affecting this stage:
-enzdes:no_unconstrained_repack will prevent this
stage from being invoked
-packing:ex1 same as for stage C
-packing:ex2 same as for stage C
-packing:use_input_sc same as for stage C
-enzdes:cst_min same as for stage C
-enzdes:bb_min same as for stage
B+C
-enzdes:chi_min same as for stage
B+C
4) Evaluating and ranking the resulting designed
sequences
In a typical enzyme design project, often hundreds or thousands
of input structures will be designed. Typically when matches are
found, they produce many structures which are very similar to
each other (i.e. they derive from matches with very similar ligand
placements). It is also recommended to redesign every starting
structure a few times, since the stochastic Monte Carlo algorithm
can lead to slightly different results every time. Together, this
means that there are thousands of designs produced by stage 3.
The problem then becomes analyzing, and ranking all of the
produced structures to find the best handful worth experimentally
characterizing. There is no perfect or ideal way to do this, and
only one of many possibilities is described here.
Every model that is output by Rosetta has the scores broken
down by residue and score type appended after the atom records.
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the best ligand score, or the best constraint score, etc.
However, the Rosetta scores don’t necessarily capture all the
important characteristics of a given design. The enzyme_design
application is set up to evaluate each output structure with respect
to the following additional properties and metrics:
-number of hydrogen bonds (in the whole protein and catalytic
residues)
-number of buried unsatisfied polar atoms (whole protein/
catalytic residues)
-non-local contacts (i.e. contacts between residues that are far
away in sequence, for both whole protein/catalytic residues)
-score across the interface between protein/ligand
-packstat [13] of the designed structure with and without ligand
present
if the option -out:file:o ,filename. is active, a scorefile containing
will be written that contains one line for every output structure. The
column labels in the score file have the following meaning:
General syntax:
pm = Column labels ending in "_pm" are determined using a
pose metric calculator
The catalytic/constrained residues are SR1, SR2, SRN for N
residues. e.g. if there is one catalytic residue only SR1. Note that if
the same catalytic residue is involved in multiple interactions (such
as in a triad), it will appear multiple times.
The ligand is the SR(N+1) and it is the last SR, e.g. if there is
one catalytic residue it is SR2.
total_score: score (excluding the restraint score)
fa_rep: full atom repulsive score
hbond_sc: hbond side chain score
all_cst: all restraint score
tot_pstat_pm: pack statistics [13]
total_nlpstat_pm: pack statistics without the li-
gand present
tot_burunsat_pm: buried unsatisfied polar atoms
Command line options affecting this stage:
-out:file:o will trigger writing
of the output file
-final_repack_without_ligand will repack the design
apo-structure and evaluate RMSD
Results
To demonstrate the Rosetta enzyme design protocol, a full
calculation for the triose phosphate isomerase (TIM)
reaction(Figure 1) was carried out. This reaction is an essential
component of glycolysis, and is one of the best-studied model
reactions in enzymology [8]. High-resolution crystal structures of
native enzymes have been obtained [11], and the fold they adopt
was named after the reaction [12]. Numerous mechanistic,
mutational and computational studies have been performed.
Here, we try to design a TIM active site into a thermophilic
scaffold of the same fold family as the native TIM.
1) Defining the theozyme
Defining the theozyme is easy in this case, since several crystal
structures of native enzymes exist, and the most important residues
in the active site have been determined previously [11]. Quantum
mechanical calculations of the natural enzyme have rationalized
the geometry observed between the catalytic residues and the
Figure 4. Crystal structure of S. cerevisiae TIM with substrate and the three most critical catalytic residues shown in stick
representation.
doi:10.1371/journal.pone.0019230.g004
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substrate atoms are labeled according to their label in the theozyme model.
doi:10.1371/journal.pone.0019230.g005
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S.cerevisiae TIM (PDB code 1ney, Figure 4) and defined according
to a mechanism advocated by Guallar et al. [8], depicted in
Figure 5. It contains three side chains: 1) a Glu/Asp (Glu165 in
1ney) to carry out two proton shuffling steps, 2) a His (His95 in
1ney) to polarize O1 and O2, the two substrate oxygen atoms that
change hybridization during the reaction, and 3) a Lys (Lys12 in
1ney) to additionally polarize O2 and facilitate the initial enolate
formation.
The geometries used in matching, shown in Figure 3 and
summarized in Table S1, are fairly constrained for the first two
side chains and more relaxed for the third interaction. For
Interaction 1, the carboxylate moiety of an Asp or Glu side chain
needs to be in a position to abstract the pro-R proton from C1. This
dictates the values for distance_AB, angle_A, and torsion_A to be
within a fairly small range. Further, since the deprotonation is
happening through the empty anti sp2 orbital of one carboxylate-
O, angle_B and torsion_B are clearly defined. There is more
freedom in the last parameter, torsion_AB, which governs the
rotation around the DHAP:C1 – Asp:OD1/2/ Glu:OE1/2, and
accordingly the matcher is set to sample a wider range for this.
For the second side chain, a His, the protonated N of the
imidazole ring needs to be between DHAP:O1 and DHAP:O2,
within hydrogen bonding distance to both, and in the plane
created by DHAP:C1, DHAP:C2, and DHAP:O2. This require-
ment clearly determines the values for distance_AB, angle_A, and
torsion_A. The protonated N-sp2 orbital is pointing between the
two oxygen atoms, and thus determining values for angle_B and
torsion_B. There is a little more variability possible for
torsion_AB, which governs the relative rotational orientation of
the imidazole plane to the substrate plane.
The third interaction, between the Lys and the DHAP, is more
loosely defined. The desired hydrogen bonding geometry between
Lys:NZ and DHAP:O2, both sp3 hybridized after the initial
reaction step, neccessitates tight ranges for the values for
distanceAB, angle_A, and angle_B. To restrict the Lys to the side
of the DHAP plane opposite of the theozyme Asp/Glu, torsion_A
is also restricted. The values for torsion_AB and torsion_B, on the
other hand, do not have much influence on the quality of the
interaction, and therefore are allowed to have any arbitrary value.
2) Matching
In the example presented here, a TIM active site will be placed
into a thermophilic scaffold with a TIM b/a barrel fold [12]. Six
scaffolds of this fold from three thermophilic organisms, listed in
table 1, were selected from the PDB. None of these proteins have
been annotated as catalyzing the TIM reaction. For each scaffold,
residues lining the natural binding pocket were selected as match
positions.
For theozyme interactions 1 and 2, as described above, the
catalytic geometry is fairly restricted, meaning that for all six
degrees of freedom there are catalytically necessitated values.
Therefore, the classic match algorithm was used to place these side
chains. To increase the number of matches found, additional
samples were done at small deviations from the ideal value.
Theozyme interaction 3, featuring two degrees of freedom that
can take on any value, is less clearly defined. Therefore the
secondary matching algorithm was used to place the Lys, and
during the matching process the torsion_B and torsion_AB
parameters between candidate Lys rotamers and potential ligand
placements were not evaluated. An overview over the matching
setup is given in Table S1, and the results of the matching stage
are in Table 1. In total, 372 unique matches were found.
3) Design
All unique matches were designed 10 times with the design
protocol as described in the methods section. Specifically, the
design shell was defined as all residues within a cut1 of 4 A ˚ and
cut2 6 A ˚ of the ligand, and the repack shell as all residues within a
cut3 of 10 A ˚ and a cut4 of 12 A ˚. The catalytic residues as found by
the matcher were considered to be part of the repack shell. This
lead to design shells having on the order of 20 residues and repack
shells on the order of 50 residues.
As a first step, all design shell residues were mutated to ALA,
and a gradient-based optimization of the poly-A structure was
done in order to optimize the catalytic interactions and ligand
position (cst_opt stage).
The structures generated by the cst_opt stage were subjected to
two rounds of design and minimization. During the design stage,
interactions between the ligand and the protein were upweighted
by a factor of 1.6, to favor the selection of sequences that make
good protein-ligand interactions with the ligand over sequences
that only make good protein-protein interactions. Further, to
reduce the number of mutations that Rosetta introduces, at every
design position the native residue identity was favored by a small
bonus of 0.8 Rosetta energy units (REU). The purpose of this is to
make sure that the native residue is kept at positions where there is
no other residue that makes clearly better interactions, such as for
exposed surface positions, hopefully avoiding inadvertent destabi-
lization of the scaffold.
The structures thus generated were then repacked and
minimized without the catalytic constraints, to ascertain the
Table 1. Matching results.
PDB ID Natural function Source organism Number of matches runtime/seconds
1tml Endocellulase T. fusca 91 6
1i4n Indole-glycerol phosphate
synthase
T. maritima 123 49
1thf Imidazole-glycerol phosphate
synthase
T. maritima 32 23
1igs Indole-glycerol phosphate
synthase
S. solfataricus 85 36
1dl3 Phosphorybosyl antranilate
isomerase
T. maritima 22 17
1qo2 Ribonucleotide isomerase T. maritima 101 42
doi:10.1371/journal.pone.0019230.t001
De Novo Enzyme Design Using Rosetta3
PLoS ONE | www.plosone.org 9 May 2011 | Volume 6 | Issue 5 | e19230unbiased conformation of the designed sequence. Finally, to test
whether the designed structures stay in the same conformation
irrespective of the presence of the ligand, the ligand is removed
and the structures repacked one last time. The complete protocol
took on the order of 8 minutes per structure, and since a total of
3720 structures were generated, the complete CPU time for this
stage was about 500 hours.
The resulting designs are then evaluated with respect to several
factors as described in the methods section. The results are in
Table 2. As a comparison, the values observed when repacking
and minimizing the native 1ney enzyme are also listed.
4) Ranking and Selection
After the design stage, the question becomes which of the
resulting 3720 designs to visually inspect and eventually select for
expression. The philosophy applied here for selecting designs
consists of two considerations: 1) for a design to be active, the
ligand needs to have a good score (i.e. binding energy), the
catalytic residues need to be in a competent conformation, and the
active site needs to be preorganized; and 2) a designed protein
must be folded, stable, soluble, and expressible in a standard E.coli
production strain.
For consideration 1, since there is a natural enzyme known, this
can be scored in Rosetta under the same conditions as the designs
were generated and used as a benchmark. Designs are then only
selected if they have comparable ligand-binding scores and
comparable catalytic-constraint scores. In terms of preorganiza-
tion, the RMSD of the catalytic residues between the final
designed structure with a ligand and the structure that was
repacked without the ligand has to be small. To enable selection of
designs according to these criteria, the model of triose phosphate
isomerase from S. cerevisia [11], was repacked and minimized in
Rosetta, with the same cstfile as used in the designs.
Regarding consideration 2, it is important to note that the
absolute Rosetta score does not necessarily correlate with
properties such as protein stability, solubility, or a clearly defined
fold. Yet, a designed protein should feature each of these. To judge
the qualities of a certain design in this regard, one approach is to
compare the designed protein to the scaffold that it originated
from. Since the original scaffold was a well behaved protein, one
can reasonably assume that a design based on it will also be,
provided that not too many of the scaffold interactions and
features have been corrupted. Here, designs were required to have
comparable score, packing quality [13], contact order, and
numbers of hydrogen bonds and buried polar atoms as the
scaffolds they came from. Table 2 shows each feature that was
used for selecting designs, together with the cutoffs used.
Of the 3720 designs, unfortunately none passed all the cutoffs,
because none of the designs featured ligand binding scores
comparable to the native. For the remaining selection parameters
however, there were generally designs that had values comparable
to the native active site or their respective scaffold. Not counting
the ligand binding energy parameter, there were 43 designs that
passed all cutoffs. The question then becomes if any of these 43
designs should be experimentally tested, or if matching in more
scaffolds should be done to find matches that give rise to designs
with better ligand binding scores. In the example design project
presented here, only 5 starting scaffolds were used, whereas in
most real-world design projects in our group, hundreds or
thousands of scaffolds are considered. If one wanted to improve
Table 2. Design results.
Feature
av. value +2 std.dev
observed in 3270 designs
lowest/highest value
observed in 3270 designs
av. value +2 std.dev
observed for repacking
1ney native 10 times
cutoff for selecting
designs
# of designs passing
cutoff
ligand binding and
catalytic site measures
total restraint score /REU 25.79+231.95 0/303.21 3.50+22.81 , 6.5 1255
restraint score catres1/REU3.47+26.01 0/149.45 0.76+20.28 ,1.2 1413
restraint score catres2/REU3.89+28.53 0/108.17 0.33+20.20 ,1.0 2136
restraint score catres 3/
REU
5.53+211.91 0/83.37 0.66+21.57 ,2.3 2696
ligand binding score/REU 22.35+21.34 27.03/2.62 29.77+20.22 ,28.5 0
active site repack rmsd w/
o ligand /A ˚
0.33+20.21 0/1.46 0.06+20.02 ,0.5 3024
catres 1 repack rmsd w/o
ligand A ˚
0.43+20.76 0/4.43 0.12+20.11 ,0.5 2737
catres 2 repack rmsd w/o
ligand A ˚
0.73+20.79 0/4.56 0.0+20.0 ,0.5 1971
catres 3 repack rmsd w/o
ligand A ˚
0.76+20.94 0/5.28 0.06+20.18 ,0.5 2121
scaffold integrity
measures / differences
to native
total score /REU 291.35+230.24 2158.97/186.32 n/a ,0.0 3705
# buried non H-bonded
polar atoms
22.10+24.94 219/19 n/a ,5 3413
# non-local contacts 6.16+23.83 210/19 n/a .22 3615
packstat [13] 20.02+20.04 20.14/0.10 n/a .20.05 2565
doi:10.1371/journal.pone.0019230.t002
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to include binding interactions with the ligand phosphate group
(which is exquisitely bound in the 1ney native) in the theozyme, so
that all matches would already feature better binding sites.
Alternatively, the selected designs can be subjected to more
thorough examination techniques such as MD simulations before
experimental characterization is attempted [14].
Discussion
The Rosetta3 enzyme design protocol as presented here
constitutes a general method to create suggestions for protein
catalysts, for any arbitrary reaction of interest. Though it has been
shown to be capable of designing active enzymes in three cases
[1,2,3], in each case the best designed proteins only had very
modest activity, while many of the designs tested had no activity at
all. Thus, while this protocol constitutes a powerful tool in the
development of novel catalysts, success is by no means guaranteed.
Several shortcomings and potentials for improvement exist, some
of which have been showcased in this study. We consider three
areas where we could improve the protocol.
First, toincrease the quality ofdesigns, itis beneficial to include as
many interactionsinthetheozymeaspossible,and concurrentlyrun
matching for as many scaffolds as possible. In the TIM example
presented here, none of the designs showed sufficient ligand binding
score, so for a new round of designs, it might be beneficial to include
ligand binding interactions in the theozyme. However, the more
complicated the theozyme becomes, the smaller the number of
matches that are found; each additional geometric requirement
made on the scaffold makes it less likely any particular scaffold will
meet all the requirements. Incorporating backbone flexibility into
the matching stage, possibly in a manner similar to the method
developed by Havranek et al. [15], would likely increase the number
of matches that can be found for complicated theozymes.
Second, the enzyme design protocol so far only considers one
state of the reactant, or one snapshot of the reaction trajectory.
This means that Rosetta will try to design a sequence that
optimally stabilizes this state, while ignoring the other states that
also occur along the reaction coordinate. For example, when
designing a catalyst for a reaction featuring large spatial
rearrangements of atoms, Rosetta might converge on a sequence
that sterically clashes with one of the substrate- or product
conformations. Natural enzymes have evolved to exquisitely
compromise between stabilization requirements for every stage
of the reaction trajectory [16]. To design efficient enzymes, it may
be that all states of the reaction need to be modeled
simultaneously, so that the designed sequence stabilizes the
transition state more than any other, without destabilizing any
other state too much. Developing a sequence selection algorithm
that simultaneously takes a complete reaction trajectory into
account is perhaps the biggest remaining challenge in computa-
tional enzyme design.
Third, ranking and selection of designs could be improved by
the development of faster more thorough computational exami-
nation methods. Often, the catalytic side chains in the final designs
will deviate from the idealized theozyme geometry. Further, the
electrostatic potential created by the designed side chains that were
not part of the theozyme also has an effect on the reaction’s energy
barrier, and thus the hypothetial stabilization achieved in a raw
theozyme might be much less, depending on what scaffold this
theozyme was placed in. Combined QM/MM hybrid approaches
might be used to address this problem, but so far these methods
are far too slow to be routinely employed for screening the
hundreds or thousands of designs that Rosetta can suggest.
Another factor that must be taken into account is the structural
integrity of the designs. Even though the Rosetta designed
sequence represents an energy minimum for the scaffold
conformation, this does not mean that this sequence cannot fold
into a different conformation. Local rearrangements of the
backbone are not unlikely and have been reported for designed
proteins. A possible method to examine designs for structural
integrity is to run MD simulations [14], although this can quickly
become prohibitively slow for large numbers of designs.
Despite the limitations listed above, from a purely practical
standpoint, the Rosetta3 enzyme design protocol is still very useful.
What distinguishes Rosetta’s computational approach is that it is
capable of generating catalytic activity from an inert scaffold,
whereas most experimental methods, such as directed evolution
approaches, rely on an existing catalytic activity as a starting point.
Rosetta designed low-activity enzymes have been evolved to
respectable catalysts [17], which shows that in combination with a
high-throughput screening or selection strategy, Rosetta can
facilitate the de novo creation of reasonable active enzymes.
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